Study: Racial disparities in treatment NSCLC persist despite gains

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A study by researchers at Thomas Jefferson University and Sidney Kimmel Cancer Center – Jefferson Health demonstrates that although Black patients are now more likely to receive the most effective treatment in non-small cell lung cancer than a decade ago, disparities persist.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

“I don’t think any good cancer center director would be worth their weight in salt if they weren’t worried about something at night,” said Mark Evers, director of University of Kentucky Markey Cancer Center.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login